Human Papillomavirus (HPV)

Human Papillomavirus (HPV) involves genital to skin contact which includes vaginal, anal, or oral sex through tiny breaks in the skin. It is not transmitted via blood or body fluids e.g., semen.

It is a common sexually transmitted virus, with more than 8 out of 10 people (80%) contracting the virus at some point in their lifetime. It can affect anyone who is or has been sexually active, even if they have only experienced sexual contact once. It is very common to be infected with one or more types of HPV shortly after sexual activity starts.

Most people do not experience any symptoms of HPV and the virus often goes away by itself. However, for some people HPV causes genital warts or cancer.

The HPV vaccine helps prevent infection with HPV that causes cervical cancer.

Eligible under the NIP in-pharmacy:

• Adolescents and young adults from 9 years to 25 years of age (optimal age for HPV vaccinations is around 12 to 13 years of age prior to exposure to HPV).
• Year 7 adolescents from 12 to 13 years (or age equivalent) who have missed vaccination through their usual School-Based Immunisation Program (SBIP).
• Catch up for adult refugees and humanitarian entrants 20 years or over who have missed their childhood vaccines.

Eligible Privately:

• Adults aged 26 and over who are likely to have previous exposure to HPV or are at an increased future risks of HPV exposure and HPV.
• Men engaging in MSM relationships of any age who have not previously been vaccinated.
• People with specific immunocompromising conditions *.

*Speak with your local 777 Pharmacist to check state eligibility to vaccinate.